The science of today is the technology of tomorrow.


Measles vaccine vectors as transgene delivery platform

Explore vector:

Delivering immunotherapeutics

  • Selective destruction of cancer cells (oncolysis)
  • Targeted immune modulation is mediated by encoded transgenes
  • Oncolysis and immune modulation lead to a personalized cancer vaccination

Vaccination against infectious diseases:
Delivering pathogen-specific antigens

  • Direct delivery of pathogen-specific antigens to immune cells
  • Antigen delivery by replicating measles vaccine is highly immunogenic
  • Induction of strong and long-term cellular and humoral immunity

There is great synergy between the vaccine program and the oncology program. The technologies for vector engineering, testing and manufacturing are identical for both programs. Expansion of the company’s Immuno-Oncology pipeline by a vaccine candidate demonstrates the vast utility and versatility of the platform technology.